WO2022065643A1 - 분비 신호서열에 융합된 표적산물 결합 단백질을 코딩하는 폴리뉴클레오티드를 포함하는 재조합 미생물, 그를 포함하는 조성물 및 그를 이용하여 표적산물을 생산하는 방법 - Google Patents
분비 신호서열에 융합된 표적산물 결합 단백질을 코딩하는 폴리뉴클레오티드를 포함하는 재조합 미생물, 그를 포함하는 조성물 및 그를 이용하여 표적산물을 생산하는 방법 Download PDFInfo
- Publication number
- WO2022065643A1 WO2022065643A1 PCT/KR2021/008714 KR2021008714W WO2022065643A1 WO 2022065643 A1 WO2022065643 A1 WO 2022065643A1 KR 2021008714 W KR2021008714 W KR 2021008714W WO 2022065643 A1 WO2022065643 A1 WO 2022065643A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- target product
- binding protein
- recombinant microorganism
- signal sequence
- secretion signal
- Prior art date
Links
- 244000005700 microbiome Species 0.000 title claims abstract description 64
- 230000028327 secretion Effects 0.000 title claims abstract description 62
- 108010076504 Protein Sorting Signals Proteins 0.000 title claims abstract description 61
- 108091008324 binding proteins Proteins 0.000 title claims abstract description 55
- 108091033319 polynucleotide Proteins 0.000 title claims abstract description 44
- 239000002157 polynucleotide Substances 0.000 title claims abstract description 44
- 102000040430 polynucleotide Human genes 0.000 title claims abstract description 44
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 21
- 239000000203 mixture Substances 0.000 title claims abstract description 10
- 102000014914 Carrier Proteins Human genes 0.000 title abstract description 48
- 239000000047 product Substances 0.000 claims description 130
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 claims description 51
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 claims description 51
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 claims description 51
- 229940031439 squalene Drugs 0.000 claims description 51
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 claims description 51
- 210000005253 yeast cell Anatomy 0.000 claims description 35
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 claims description 32
- 235000013734 beta-carotene Nutrition 0.000 claims description 32
- 239000011648 beta-carotene Substances 0.000 claims description 32
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 claims description 32
- 229960002747 betacarotene Drugs 0.000 claims description 32
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 claims description 32
- GLZPCOQZEFWAFX-UHFFFAOYSA-N Geraniol Chemical compound CC(C)=CCCC(C)=CCO GLZPCOQZEFWAFX-UHFFFAOYSA-N 0.000 claims description 24
- 150000001875 compounds Chemical class 0.000 claims description 22
- 238000000034 method Methods 0.000 claims description 19
- 230000027455 binding Effects 0.000 claims description 16
- 238000012258 culturing Methods 0.000 claims description 16
- 238000012239 gene modification Methods 0.000 claims description 13
- 230000005017 genetic modification Effects 0.000 claims description 13
- 235000013617 genetically modified food Nutrition 0.000 claims description 13
- GRWFGVWFFZKLTI-IUCAKERBSA-N (-)-α-pinene Chemical compound CC1=CC[C@@H]2C(C)(C)[C@H]1C2 GRWFGVWFFZKLTI-IUCAKERBSA-N 0.000 claims description 12
- JSNRRGGBADWTMC-UHFFFAOYSA-N (6E)-7,11-dimethyl-3-methylene-1,6,10-dodecatriene Chemical compound CC(C)=CCCC(C)=CCCC(=C)C=C JSNRRGGBADWTMC-UHFFFAOYSA-N 0.000 claims description 12
- GGYKPYDKXLHNTI-UHFFFAOYSA-N 2,6,10,14-tetramethylhexadecane Chemical compound CCC(C)CCCC(C)CCCC(C)CCCC(C)C GGYKPYDKXLHNTI-UHFFFAOYSA-N 0.000 claims description 12
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 12
- UAHWPYUMFXYFJY-UHFFFAOYSA-N beta-myrcene Chemical compound CC(C)=CCCC(=C)C=C UAHWPYUMFXYFJY-UHFFFAOYSA-N 0.000 claims description 12
- ULDHMXUKGWMISQ-UHFFFAOYSA-N carvone Chemical compound CC(=C)C1CC=C(C)C(=O)C1 ULDHMXUKGWMISQ-UHFFFAOYSA-N 0.000 claims description 12
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 claims description 12
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 claims description 12
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 claims description 12
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 claims description 11
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 claims description 11
- 101710097927 Retinal-binding protein Proteins 0.000 claims description 11
- 235000012661 lycopene Nutrition 0.000 claims description 11
- 239000001751 lycopene Substances 0.000 claims description 11
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 claims description 11
- 229960004999 lycopene Drugs 0.000 claims description 11
- 102000024458 retinal binding proteins Human genes 0.000 claims description 11
- -1 terpenoid compound Chemical class 0.000 claims description 11
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 claims description 11
- 101150012394 PHO5 gene Proteins 0.000 claims description 10
- 239000002207 metabolite Substances 0.000 claims description 10
- 239000006228 supernatant Substances 0.000 claims description 9
- 101710129138 ATP synthase subunit 9, mitochondrial Proteins 0.000 claims description 7
- 101710168506 ATP synthase subunit C, plastid Proteins 0.000 claims description 7
- 101710114069 ATP synthase subunit c Proteins 0.000 claims description 7
- 101710197943 ATP synthase subunit c, chloroplastic Proteins 0.000 claims description 7
- 101710187091 ATP synthase subunit c, sodium ion specific Proteins 0.000 claims description 7
- FSLPMRQHCOLESF-UHFFFAOYSA-N alpha-amyrenol Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C)C(C)C5C4=CCC3C21C FSLPMRQHCOLESF-UHFFFAOYSA-N 0.000 claims description 7
- JFSHUTJDVKUMTJ-QHPUVITPSA-N beta-amyrin Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C JFSHUTJDVKUMTJ-QHPUVITPSA-N 0.000 claims description 7
- QQFMRPIKDLHLKB-UHFFFAOYSA-N beta-amyrin Natural products CC1C2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C)CCC1(C)C QQFMRPIKDLHLKB-UHFFFAOYSA-N 0.000 claims description 7
- PDNLMONKODEGSE-UHFFFAOYSA-N beta-amyrin acetate Natural products CC(=O)OC1CCC2(C)C(CCC3(C)C4(C)CCC5(C)CCC(C)(C)CC5C4=CCC23C)C1(C)C PDNLMONKODEGSE-UHFFFAOYSA-N 0.000 claims description 7
- 239000012634 fragment Substances 0.000 claims description 7
- 102000019758 lipid binding proteins Human genes 0.000 claims description 7
- 150000002632 lipids Chemical class 0.000 claims description 7
- FQTLCLSUCSAZDY-UHFFFAOYSA-N (+) E(S) nerolidol Natural products CC(C)=CCCC(C)=CCCC(C)(O)C=C FQTLCLSUCSAZDY-UHFFFAOYSA-N 0.000 claims description 6
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 claims description 6
- QEBNYNLSCGVZOH-NFAWXSAZSA-N (+)-valencene Chemical compound C1C[C@@H](C(C)=C)C[C@@]2(C)[C@H](C)CCC=C21 QEBNYNLSCGVZOH-NFAWXSAZSA-N 0.000 claims description 6
- IVZWRQBQDVHDNG-UHFFFAOYSA-N (-)-Kauran; alpha-Dihydrokauren Natural products C1CC2C3(C)CCCC(C)(C)C3CCC22CC(C)C1C2 IVZWRQBQDVHDNG-UHFFFAOYSA-N 0.000 claims description 6
- XZRVRYFILCSYSP-OAHLLOKOSA-N (-)-beta-bisabolene Chemical compound CC(C)=CCCC(=C)[C@H]1CCC(C)=CC1 XZRVRYFILCSYSP-OAHLLOKOSA-N 0.000 claims description 6
- 239000001890 (2R)-8,8,8a-trimethyl-2-prop-1-en-2-yl-1,2,3,4,6,7-hexahydronaphthalene Substances 0.000 claims description 6
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 claims description 6
- ABTRFGSPYXCGMR-KXQOOQHDSA-N (3R)-beta,psi-caroten-3-ol Chemical compound CC(C)=CCCC(C)=CC=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C ABTRFGSPYXCGMR-KXQOOQHDSA-N 0.000 claims description 6
- JKQXZKUSFCKOGQ-JLGXGRJMSA-N (3R,3'R)-beta,beta-carotene-3,3'-diol Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-JLGXGRJMSA-N 0.000 claims description 6
- JSNRRGGBADWTMC-QINSGFPZSA-N (E)-beta-Farnesene Natural products CC(C)=CCC\C(C)=C/CCC(=C)C=C JSNRRGGBADWTMC-QINSGFPZSA-N 0.000 claims description 6
- 239000001707 (E,7R,11R)-3,7,11,15-tetramethylhexadec-2-en-1-ol Substances 0.000 claims description 6
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 claims description 6
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 claims description 6
- QYIMSPSDBYKPPY-RSKUXYSASA-N (S)-2,3-epoxysqualene Chemical group CC(C)=CCC\C(C)=C\CC\C(C)=C\CC\C=C(/C)CC\C=C(/C)CC[C@@H]1OC1(C)C QYIMSPSDBYKPPY-RSKUXYSASA-N 0.000 claims description 6
- TYDDWHVJHGIJCW-OLKPEBQYSA-N (Z)-Ocimene Natural products O[C@@H](C(=C)C)C/C=C(/C=C)\C TYDDWHVJHGIJCW-OLKPEBQYSA-N 0.000 claims description 6
- IHPKGUQCSIINRJ-NTMALXAHSA-N (Z)-beta-ocimene Chemical compound CC(C)=CC\C=C(\C)C=C IHPKGUQCSIINRJ-NTMALXAHSA-N 0.000 claims description 6
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 6
- 102100031663 Alpha-tocopherol transfer protein Human genes 0.000 claims description 6
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 claims description 6
- YMTCQCWFYXOJRY-UHFFFAOYSA-N Bedfordiaditerpenalcohol Natural products OCC=C(C)CCC1(C)C(C)CCC2(C)C1CCCC2=C YMTCQCWFYXOJRY-UHFFFAOYSA-N 0.000 claims description 6
- BXXSHQYDJWZXPB-OKNSCYNVSA-N Capsidiol Chemical compound C1[C@@H](C(C)=C)C[C@]2(C)[C@H](C)[C@H](O)C[C@@H](O)C2=C1 BXXSHQYDJWZXPB-OKNSCYNVSA-N 0.000 claims description 6
- BXXSHQYDJWZXPB-WPTOEGHWSA-N Capsidiol Natural products O[C@@H]1[C@H](C)[C@]2(C)C([C@H](O)C1)=CC[C@@H](C(=C)C)C2 BXXSHQYDJWZXPB-WPTOEGHWSA-N 0.000 claims description 6
- 239000005973 Carvone Substances 0.000 claims description 6
- 241000723346 Cinnamomum camphora Species 0.000 claims description 6
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 claims description 6
- GLZPCOQZEFWAFX-YFHOEESVSA-N Geraniol Natural products CC(C)=CCC\C(C)=C/CO GLZPCOQZEFWAFX-YFHOEESVSA-N 0.000 claims description 6
- 239000005792 Geraniol Substances 0.000 claims description 6
- GLZPCOQZEFWAFX-JXMROGBWSA-N Nerol Natural products CC(C)=CCC\C(C)=C\CO GLZPCOQZEFWAFX-JXMROGBWSA-N 0.000 claims description 6
- FQTLCLSUCSAZDY-ATGUSINASA-N Nerolidol Chemical compound CC(C)=CCC\C(C)=C\CC[C@](C)(O)C=C FQTLCLSUCSAZDY-ATGUSINASA-N 0.000 claims description 6
- XOJVVFBFDXDTEG-UHFFFAOYSA-N Norphytane Natural products CC(C)CCCC(C)CCCC(C)CCCC(C)C XOJVVFBFDXDTEG-UHFFFAOYSA-N 0.000 claims description 6
- QYIMSPSDBYKPPY-UHFFFAOYSA-N OS Natural products CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC1OC1(C)C QYIMSPSDBYKPPY-UHFFFAOYSA-N 0.000 claims description 6
- BLUHKGOSFDHHGX-UHFFFAOYSA-N Phytol Natural products CC(C)CCCC(C)CCCC(C)CCCC(C)C=CO BLUHKGOSFDHHGX-UHFFFAOYSA-N 0.000 claims description 6
- 241000235070 Saccharomyces Species 0.000 claims description 6
- 229940123237 Taxane Drugs 0.000 claims description 6
- HNZBNQYXWOLKBA-UHFFFAOYSA-N Tetrahydrofarnesol Natural products CC(C)CCCC(C)CCCC(C)=CCO HNZBNQYXWOLKBA-UHFFFAOYSA-N 0.000 claims description 6
- JKQXZKUSFCKOGQ-LQFQNGICSA-N Z-zeaxanthin Natural products C([C@H](O)CC=1C)C(C)(C)C=1C=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-LQFQNGICSA-N 0.000 claims description 6
- QOPRSMDTRDMBNK-RNUUUQFGSA-N Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCC(O)C1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C QOPRSMDTRDMBNK-RNUUUQFGSA-N 0.000 claims description 6
- 229930000074 abietane Natural products 0.000 claims description 6
- STIVVCHBLMGYSL-ZYNAIFEFSA-N abietane Chemical compound CC1(C)CCC[C@]2(C)[C@H]3CC[C@H](C(C)C)C[C@@H]3CC[C@H]21 STIVVCHBLMGYSL-ZYNAIFEFSA-N 0.000 claims description 6
- BOTWFXYSPFMFNR-OALUTQOASA-N all-rac-phytol Natural products CC(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)=CCO BOTWFXYSPFMFNR-OALUTQOASA-N 0.000 claims description 6
- JKQXZKUSFCKOGQ-LOFNIBRQSA-N all-trans-Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C JKQXZKUSFCKOGQ-LOFNIBRQSA-N 0.000 claims description 6
- FSLPMRQHCOLESF-SFMCKYFRSA-N alpha-amyrin Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C FSLPMRQHCOLESF-SFMCKYFRSA-N 0.000 claims description 6
- SJMCNAVDHDBMLL-UHFFFAOYSA-N alpha-amyrin Natural products CC1CCC2(C)CCC3(C)C(=CCC4C5(C)CCC(O)CC5CCC34C)C2C1C SJMCNAVDHDBMLL-UHFFFAOYSA-N 0.000 claims description 6
- GJYJYFHBOBUTBY-UHFFFAOYSA-N alpha-camphorene Chemical compound CC(C)=CCCC(=C)C1CCC(CCC=C(C)C)=CC1 GJYJYFHBOBUTBY-UHFFFAOYSA-N 0.000 claims description 6
- 229930010863 alpha-cedrane Natural products 0.000 claims description 6
- VYBREYKSZAROCT-UHFFFAOYSA-N alpha-myrcene Natural products CC(=C)CCCC(=C)C=C VYBREYKSZAROCT-UHFFFAOYSA-N 0.000 claims description 6
- MVNCAPSFBDBCGF-UHFFFAOYSA-N alpha-pinene Natural products CC1=CCC23C1CC2C3(C)C MVNCAPSFBDBCGF-UHFFFAOYSA-N 0.000 claims description 6
- 108010078068 alpha-tocopherol transfer protein Proteins 0.000 claims description 6
- HMTAHNDPLDKYJT-CBBWQLFWSA-N amorpha-4,11-diene Chemical compound C1=C(C)CC[C@H]2[C@H](C)CC[C@@H](C(C)=C)[C@H]21 HMTAHNDPLDKYJT-CBBWQLFWSA-N 0.000 claims description 6
- HMTAHNDPLDKYJT-UHFFFAOYSA-N amorphadiene Natural products C1=C(C)CCC2C(C)CCC(C(C)=C)C21 HMTAHNDPLDKYJT-UHFFFAOYSA-N 0.000 claims description 6
- BLUAFEHZUWYNDE-NNWCWBAJSA-N artemisinin Chemical compound C([C@](OO1)(C)O2)C[C@H]3[C@H](C)CC[C@@H]4[C@@]31[C@@H]2OC(=O)[C@@H]4C BLUAFEHZUWYNDE-NNWCWBAJSA-N 0.000 claims description 6
- 229930101531 artemisinin Natural products 0.000 claims description 6
- 229960004191 artemisinin Drugs 0.000 claims description 6
- 235000013793 astaxanthin Nutrition 0.000 claims description 6
- 239000001168 astaxanthin Substances 0.000 claims description 6
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 claims description 6
- 229940022405 astaxanthin Drugs 0.000 claims description 6
- XZRVRYFILCSYSP-UHFFFAOYSA-N beta-Bisabolene Natural products CC(C)=CCCC(=C)C1CCC(C)=CC1 XZRVRYFILCSYSP-UHFFFAOYSA-N 0.000 claims description 6
- YSNRTFFURISHOU-UHFFFAOYSA-N beta-farnesene Natural products C=CC(C)CCC=C(C)CCC=C(C)C YSNRTFFURISHOU-UHFFFAOYSA-N 0.000 claims description 6
- 229930008380 camphor Natural products 0.000 claims description 6
- 229960000846 camphor Drugs 0.000 claims description 6
- RECUKUPTGUEGMW-UHFFFAOYSA-N carvacrol Chemical compound CC(C)C1=CC=C(C)C(O)=C1 RECUKUPTGUEGMW-UHFFFAOYSA-N 0.000 claims description 6
- HHTWOMMSBMNRKP-UHFFFAOYSA-N carvacrol Natural products CC(=C)C1=CC=C(C)C(O)=C1 HHTWOMMSBMNRKP-UHFFFAOYSA-N 0.000 claims description 6
- 235000007746 carvacrol Nutrition 0.000 claims description 6
- JJTQQGNEXQKQRF-BIGJJFBESA-N cedrane Chemical compound C1[C@]23[C@H](C)CC[C@H]3C(C)(C)[C@@H]1[C@H](C)CC2 JJTQQGNEXQKQRF-BIGJJFBESA-N 0.000 claims description 6
- 230000001413 cellular effect Effects 0.000 claims description 6
- UKXNCRFTOXSKTE-KFCWCOGWSA-N clerodane Chemical compound C[C@H]1CCC[C@@H]2[C@](CCC(C)CC)(C)[C@H](C)CC[C@]21C UKXNCRFTOXSKTE-KFCWCOGWSA-N 0.000 claims description 6
- IVZWRQBQDVHDNG-KUIXFMFUSA-N ent-kaurane Chemical compound C([C@@]1(C)[C@@H]2CC3)CCC(C)(C)[C@H]1CC[C@]21C[C@H](C)[C@H]3C1 IVZWRQBQDVHDNG-KUIXFMFUSA-N 0.000 claims description 6
- 229940113087 geraniol Drugs 0.000 claims description 6
- WYXXLXHHWYNKJF-UHFFFAOYSA-N isocarvacrol Natural products CC(C)C1=CC=C(O)C(C)=C1 WYXXLXHHWYNKJF-UHFFFAOYSA-N 0.000 claims description 6
- 229930001567 kaurane Natural products 0.000 claims description 6
- LEWJAHURGICVRE-AISVETHESA-N labdane Chemical compound CC1(C)CCC[C@]2(C)[C@@H](CC[C@H](C)CC)[C@@H](C)CC[C@H]21 LEWJAHURGICVRE-AISVETHESA-N 0.000 claims description 6
- 235000001510 limonene Nutrition 0.000 claims description 6
- 229940087305 limonene Drugs 0.000 claims description 6
- 229930007744 linalool Natural products 0.000 claims description 6
- 239000001656 lutein Substances 0.000 claims description 6
- 235000012680 lutein Nutrition 0.000 claims description 6
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 claims description 6
- 229960005375 lutein Drugs 0.000 claims description 6
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 claims description 6
- 229940041616 menthol Drugs 0.000 claims description 6
- 230000037353 metabolic pathway Effects 0.000 claims description 6
- WASNIKZYIWZQIP-AWEZNQCLSA-N nerolidol Natural products CC(=CCCC(=CCC[C@@H](O)C=C)C)C WASNIKZYIWZQIP-AWEZNQCLSA-N 0.000 claims description 6
- BOTWFXYSPFMFNR-PYDDKJGSSA-N phytol Chemical compound CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC\C(C)=C\CO BOTWFXYSPFMFNR-PYDDKJGSSA-N 0.000 claims description 6
- GZHFBZCDMVGRTI-DIJYYDPMSA-N pimarane Chemical compound CC1(C)CCC[C@]2(C)[C@H]3CC[C@](CC)(C)C[C@@H]3CCC21 GZHFBZCDMVGRTI-DIJYYDPMSA-N 0.000 claims description 6
- 229930000776 pimarane Natural products 0.000 claims description 6
- GRWFGVWFFZKLTI-UHFFFAOYSA-N rac-alpha-Pinene Natural products CC1=CCC2C(C)(C)C1C2 GRWFGVWFFZKLTI-UHFFFAOYSA-N 0.000 claims description 6
- 235000020944 retinol Nutrition 0.000 claims description 6
- 239000011607 retinol Substances 0.000 claims description 6
- 229960003471 retinol Drugs 0.000 claims description 6
- 235000009514 rubixanthin Nutrition 0.000 claims description 6
- 239000000455 rubixanthin Substances 0.000 claims description 6
- ABTRFGSPYXCGMR-SDPRXREBSA-N rubixanthin Natural products O[C@H]1CC(C)(C)C(/C=C/C(=C\C=C\C(=C/C=C/C=C(\C=C\C=C(/C=C/C=C(\CC/C=C(\C)/C)/C)\C)/C)\C)/C)=C(C)C1 ABTRFGSPYXCGMR-SDPRXREBSA-N 0.000 claims description 6
- DKPFODGZWDEEBT-QFIAKTPHSA-N taxane Chemical class C([C@]1(C)CCC[C@@H](C)[C@H]1C1)C[C@H]2[C@H](C)CC[C@@H]1C2(C)C DKPFODGZWDEEBT-QFIAKTPHSA-N 0.000 claims description 6
- XJPBRODHZKDRCB-UHFFFAOYSA-N trans-alpha-ocimene Natural products CC(=C)CCC=C(C)C=C XJPBRODHZKDRCB-UHFFFAOYSA-N 0.000 claims description 6
- WCTNXGFHEZQHDR-UHFFFAOYSA-N valencene Natural products C1CC(C)(C)C2(C)CC(C(=C)C)CCC2=C1 WCTNXGFHEZQHDR-UHFFFAOYSA-N 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 claims description 6
- 235000010930 zeaxanthin Nutrition 0.000 claims description 6
- 239000001775 zeaxanthin Substances 0.000 claims description 6
- 229940043269 zeaxanthin Drugs 0.000 claims description 6
- IHPKGUQCSIINRJ-UHFFFAOYSA-N β-ocimene Natural products CC(C)=CCC=C(C)C=C IHPKGUQCSIINRJ-UHFFFAOYSA-N 0.000 claims description 6
- MIJYXULNPSFWEK-GTOFXWBISA-N 3beta-hydroxyolean-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MIJYXULNPSFWEK-GTOFXWBISA-N 0.000 claims description 5
- 241000238366 Cephalopoda Species 0.000 claims description 5
- JKLISIRFYWXLQG-UHFFFAOYSA-N Epioleonolsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4CCC3C21C JKLISIRFYWXLQG-UHFFFAOYSA-N 0.000 claims description 5
- YBRJHZPWOMJYKQ-UHFFFAOYSA-N Oleanolic acid Natural products CC1(C)CC2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C1)C(=O)O YBRJHZPWOMJYKQ-UHFFFAOYSA-N 0.000 claims description 5
- MIJYXULNPSFWEK-UHFFFAOYSA-N Oleanolinsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MIJYXULNPSFWEK-UHFFFAOYSA-N 0.000 claims description 5
- 229940100243 oleanolic acid Drugs 0.000 claims description 5
- HZLWUYJLOIAQFC-UHFFFAOYSA-N prosapogenin PS-A Natural products C12CC(C)(C)CCC2(C(O)=O)CCC(C2(CCC3C4(C)C)C)(C)C1=CCC2C3(C)CCC4OC1OCC(O)C(O)C1O HZLWUYJLOIAQFC-UHFFFAOYSA-N 0.000 claims description 5
- CGVXVPQJMYMMIH-HKDZDBKOSA-N tigliane Chemical compound C1[C@H](C)C[C@H]2[C@@H]3C(C)(C)[C@@H]3C[C@@H](C)[C@@H]2[C@@H]2C[C@H](C)C[C@H]21 CGVXVPQJMYMMIH-HKDZDBKOSA-N 0.000 claims description 5
- 102000023732 binding proteins Human genes 0.000 claims 7
- 210000004027 cell Anatomy 0.000 description 44
- 108090000623 proteins and genes Proteins 0.000 description 40
- SNRUBQQJIBEYMU-UHFFFAOYSA-N dodecane Chemical compound CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 description 34
- 150000001413 amino acids Chemical class 0.000 description 27
- 239000002609 medium Substances 0.000 description 24
- 108020001507 fusion proteins Proteins 0.000 description 21
- 150000003505 terpenes Chemical class 0.000 description 18
- 102000004169 proteins and genes Human genes 0.000 description 17
- 102100035174 SEC14-like protein 2 Human genes 0.000 description 16
- 101710188106 SEC14-like protein 2 Proteins 0.000 description 16
- 239000013598 vector Substances 0.000 description 16
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 13
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 13
- 102000037865 fusion proteins Human genes 0.000 description 13
- 230000003834 intracellular effect Effects 0.000 description 13
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 12
- 230000006696 biosynthetic metabolic pathway Effects 0.000 description 9
- 230000015572 biosynthetic process Effects 0.000 description 9
- 101150084072 ERG20 gene Proteins 0.000 description 8
- 101150009006 HIS3 gene Proteins 0.000 description 8
- 108091028043 Nucleic acid sequence Proteins 0.000 description 8
- 101100127715 Phaffia rhodozyma crtYB gene Proteins 0.000 description 7
- 101100394989 Rhodopseudomonas palustris (strain ATCC BAA-98 / CGA009) hisI gene Proteins 0.000 description 7
- 101100114901 Streptomyces griseus crtI gene Proteins 0.000 description 7
- 239000013592 cell lysate Substances 0.000 description 7
- 101150000046 crtE gene Proteins 0.000 description 7
- 239000002773 nucleotide Substances 0.000 description 7
- 125000003729 nucleotide group Chemical group 0.000 description 7
- CABVTRNMFUVUDM-VRHQGPGLSA-N (3S)-3-hydroxy-3-methylglutaryl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)C[C@@](O)(CC(O)=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 CABVTRNMFUVUDM-VRHQGPGLSA-N 0.000 description 6
- ZRLNBWWGLOPJIC-PYQRSULMSA-N A'-neogammacerane Chemical compound C([C@]1(C)[C@H]2CC[C@H]34)CCC(C)(C)[C@@H]1CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@@H]1C(C)C ZRLNBWWGLOPJIC-PYQRSULMSA-N 0.000 description 6
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- 238000004128 high performance liquid chromatography Methods 0.000 description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 6
- 229910052757 nitrogen Inorganic materials 0.000 description 6
- 230000008569 process Effects 0.000 description 6
- 230000001105 regulatory effect Effects 0.000 description 6
- 241000894006 Bacteria Species 0.000 description 5
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 5
- 101100061456 Streptomyces griseus crtB gene Proteins 0.000 description 5
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 5
- 229910052799 carbon Inorganic materials 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 101150011633 crtI gene Proteins 0.000 description 5
- 238000010586 diagram Methods 0.000 description 5
- 239000012528 membrane Substances 0.000 description 5
- 239000001301 oxygen Substances 0.000 description 5
- 229910052760 oxygen Inorganic materials 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- YVLPJIGOMTXXLP-UHFFFAOYSA-N 15-cis-phytoene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC(C)=CC=CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C YVLPJIGOMTXXLP-UHFFFAOYSA-N 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 4
- 239000002033 PVDF binder Substances 0.000 description 4
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 4
- 150000001335 aliphatic alkanes Chemical class 0.000 description 4
- 239000012228 culture supernatant Substances 0.000 description 4
- DIOQZVSQGTUSAI-UHFFFAOYSA-N decane Chemical compound CCCCCCCCCC DIOQZVSQGTUSAI-UHFFFAOYSA-N 0.000 description 4
- 239000013604 expression vector Substances 0.000 description 4
- 239000008103 glucose Substances 0.000 description 4
- DCAYPVUWAIABOU-UHFFFAOYSA-N hexadecane Chemical compound CCCCCCCCCCCCCCCC DCAYPVUWAIABOU-UHFFFAOYSA-N 0.000 description 4
- 229920002981 polyvinylidene fluoride Polymers 0.000 description 4
- 230000003248 secreting effect Effects 0.000 description 4
- KJTLQQUUPVSXIM-ZCFIWIBFSA-N (R)-mevalonic acid Chemical compound OCC[C@](O)(C)CC(O)=O KJTLQQUUPVSXIM-ZCFIWIBFSA-N 0.000 description 3
- KJTLQQUUPVSXIM-UHFFFAOYSA-N DL-mevalonic acid Natural products OCCC(O)(C)CC(O)=O KJTLQQUUPVSXIM-UHFFFAOYSA-N 0.000 description 3
- OINNEUNVOZHBOX-XBQSVVNOSA-N Geranylgeranyl diphosphate Natural products [P@](=O)(OP(=O)(O)O)(OC/C=C(\CC/C=C(\CC/C=C(\CC/C=C(\C)/C)/C)/C)/C)O OINNEUNVOZHBOX-XBQSVVNOSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 230000010261 cell growth Effects 0.000 description 3
- 210000003527 eukaryotic cell Anatomy 0.000 description 3
- OINNEUNVOZHBOX-KGODAQDXSA-N geranylgeranyl diphosphate Chemical compound CC(C)=CCC\C(C)=C/CC\C(C)=C\CC\C(C)=C\CO[P@@](O)(=O)OP(O)(O)=O OINNEUNVOZHBOX-KGODAQDXSA-N 0.000 description 3
- 239000003446 ligand Substances 0.000 description 3
- 230000000813 microbial effect Effects 0.000 description 3
- 230000037361 pathway Effects 0.000 description 3
- 229920001184 polypeptide Polymers 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- 102000004196 processed proteins & peptides Human genes 0.000 description 3
- 210000001236 prokaryotic cell Anatomy 0.000 description 3
- 238000001262 western blot Methods 0.000 description 3
- YVLPJIGOMTXXLP-UUKUAVTLSA-N 15,15'-cis-Phytoene Natural products C(=C\C=C/C=C(\CC/C=C(\CC/C=C(\CC/C=C(\C)/C)/C)/C)/C)(\CC/C=C(\CC/C=C(\CC/C=C(\C)/C)/C)/C)/C YVLPJIGOMTXXLP-UUKUAVTLSA-N 0.000 description 2
- YVLPJIGOMTXXLP-BAHRDPFUSA-N 15Z-phytoene Natural products CC(=CCCC(=CCCC(=CCCC(=CC=C/C=C(C)/CCC=C(/C)CCC=C(/C)CCC=C(C)C)C)C)C)C YVLPJIGOMTXXLP-BAHRDPFUSA-N 0.000 description 2
- 108010039636 3-isopropylmalate dehydrogenase Proteins 0.000 description 2
- 101000636215 Crotalus durissus terrificus Crotamine Proteins 0.000 description 2
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- VWFJDQUYCIWHTN-UHFFFAOYSA-N Farnesyl pyrophosphate Natural products CC(C)=CCCC(C)=CCCC(C)=CCOP(O)(=O)OP(O)(O)=O VWFJDQUYCIWHTN-UHFFFAOYSA-N 0.000 description 2
- 102000004286 Hydroxymethylglutaryl CoA Reductases Human genes 0.000 description 2
- 108090000895 Hydroxymethylglutaryl CoA Reductases Proteins 0.000 description 2
- RRHGJUQNOFWUDK-UHFFFAOYSA-N Isoprene Chemical compound CC(=C)C=C RRHGJUQNOFWUDK-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- ZJPGOXWRFNKIQL-JYJNAYRXSA-N Phe-Pro-Pro Chemical compound C([C@H](N)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(O)=O)C1=CC=CC=C1 ZJPGOXWRFNKIQL-JYJNAYRXSA-N 0.000 description 2
- 101100010928 Saccharolobus solfataricus (strain ATCC 35092 / DSM 1617 / JCM 11322 / P2) tuf gene Proteins 0.000 description 2
- 239000006180 TBST buffer Substances 0.000 description 2
- 101150001810 TEAD1 gene Proteins 0.000 description 2
- 101150074253 TEF1 gene Proteins 0.000 description 2
- 102100029898 Transcriptional enhancer factor TEF-1 Human genes 0.000 description 2
- ZSLZBFCDCINBPY-ZSJPKINUSA-N acetyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 ZSLZBFCDCINBPY-ZSJPKINUSA-N 0.000 description 2
- 210000004899 c-terminal region Anatomy 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 238000012790 confirmation Methods 0.000 description 2
- 238000012937 correction Methods 0.000 description 2
- 229910001882 dioxygen Inorganic materials 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 210000002472 endoplasmic reticulum Anatomy 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 210000002288 golgi apparatus Anatomy 0.000 description 2
- 230000002209 hydrophobic effect Effects 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 230000004576 lipid-binding Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000012913 medium supplement Substances 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 238000003032 molecular docking Methods 0.000 description 2
- 235000011765 phytoene Nutrition 0.000 description 2
- 239000013612 plasmid Substances 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 230000006798 recombination Effects 0.000 description 2
- 238000005215 recombination Methods 0.000 description 2
- 108091008146 restriction endonucleases Proteins 0.000 description 2
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 2
- 230000009870 specific binding Effects 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- 238000013519 translation Methods 0.000 description 2
- 229940035893 uracil Drugs 0.000 description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 description 2
- 239000008158 vegetable oil Substances 0.000 description 2
- BQPPJGMMIYJVBR-UHFFFAOYSA-N (10S)-3c-Acetoxy-4.4.10r.13c.14t-pentamethyl-17c-((R)-1.5-dimethyl-hexen-(4)-yl)-(5tH)-Delta8-tetradecahydro-1H-cyclopenta[a]phenanthren Natural products CC12CCC(OC(C)=O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C)CCC21C BQPPJGMMIYJVBR-UHFFFAOYSA-N 0.000 description 1
- SBKVPJHMSUXZTA-MEJXFZFPSA-N (2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-5-amino-2-[[2-[[(2S)-1-[(2S)-6-amino-2-[[(2S)-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-3-(1H-indol-3-yl)propanoyl]amino]-3-(1H-imidazol-4-yl)propanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-4-methylpentanoyl]amino]-5-oxopentanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]pyrrolidine-2-carbonyl]amino]acetyl]amino]-5-oxopentanoyl]pyrrolidine-2-carbonyl]amino]-4-methylsulfanylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoic acid Chemical compound C([C@@H](C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)NC(=O)[C@@H](N)CC=1C2=CC=CC=C2NC=1)C1=CNC=N1 SBKVPJHMSUXZTA-MEJXFZFPSA-N 0.000 description 1
- CHGIKSSZNBCNDW-UHFFFAOYSA-N (3beta,5alpha)-4,4-Dimethylcholesta-8,24-dien-3-ol Natural products CC12CCC(O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C)CCC21 CHGIKSSZNBCNDW-UHFFFAOYSA-N 0.000 description 1
- GZCWLCBFPRFLKL-UHFFFAOYSA-N 1-prop-2-ynoxypropan-2-ol Chemical compound CC(O)COCC#C GZCWLCBFPRFLKL-UHFFFAOYSA-N 0.000 description 1
- XYTLYKGXLMKYMV-UHFFFAOYSA-N 14alpha-methylzymosterol Natural products CC12CCC(O)CC1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C)CCC21C XYTLYKGXLMKYMV-UHFFFAOYSA-N 0.000 description 1
- VWFJDQUYCIWHTN-YFVJMOTDSA-N 2-trans,6-trans-farnesyl diphosphate Chemical compound CC(C)=CCC\C(C)=C\CC\C(C)=C\CO[P@](O)(=O)OP(O)(O)=O VWFJDQUYCIWHTN-YFVJMOTDSA-N 0.000 description 1
- FPTJELQXIUUCEY-UHFFFAOYSA-N 3beta-Hydroxy-lanostan Natural products C1CC2C(C)(C)C(O)CCC2(C)C2C1C1(C)CCC(C(C)CCCC(C)C)C1(C)CC2 FPTJELQXIUUCEY-UHFFFAOYSA-N 0.000 description 1
- 108010051457 Acid Phosphatase Proteins 0.000 description 1
- 102000013563 Acid Phosphatase Human genes 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 241000186216 Corynebacterium Species 0.000 description 1
- 241000186226 Corynebacterium glutamicum Species 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- 241000588722 Escherichia Species 0.000 description 1
- 108050001049 Extracellular proteins Proteins 0.000 description 1
- VWFJDQUYCIWHTN-FBXUGWQNSA-N Farnesyl diphosphate Natural products CC(C)=CCC\C(C)=C/CC\C(C)=C/COP(O)(=O)OP(O)(O)=O VWFJDQUYCIWHTN-FBXUGWQNSA-N 0.000 description 1
- 102100035111 Farnesyl pyrophosphate synthase Human genes 0.000 description 1
- 101710125754 Farnesyl pyrophosphate synthase Proteins 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 102000013404 Geranyltranstransferase Human genes 0.000 description 1
- 108010026318 Geranyltranstransferase Proteins 0.000 description 1
- BKLIAINBCQPSOV-UHFFFAOYSA-N Gluanol Natural products CC(C)CC=CC(C)C1CCC2(C)C3=C(CCC12C)C4(C)CCC(O)C(C)(C)C4CC3 BKLIAINBCQPSOV-UHFFFAOYSA-N 0.000 description 1
- 102100036669 Glycerol-3-phosphate dehydrogenase [NAD(+)], cytoplasmic Human genes 0.000 description 1
- 101710088172 HTH-type transcriptional regulator RipA Proteins 0.000 description 1
- 108010003774 Histidinol-phosphatase Proteins 0.000 description 1
- 101001072574 Homo sapiens Glycerol-3-phosphate dehydrogenase [NAD(+)], cytoplasmic Proteins 0.000 description 1
- 108090001042 Hydro-Lyases Proteins 0.000 description 1
- 102000004867 Hydro-Lyases Human genes 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- 241000194036 Lactococcus Species 0.000 description 1
- LOPKHWOTGJIQLC-UHFFFAOYSA-N Lanosterol Natural products CC(CCC=C(C)C)C1CCC2(C)C3=C(CCC12C)C4(C)CCC(C)(O)C(C)(C)C4CC3 LOPKHWOTGJIQLC-UHFFFAOYSA-N 0.000 description 1
- 108010038049 Mating Factor Proteins 0.000 description 1
- 108010006519 Molecular Chaperones Proteins 0.000 description 1
- 102000005431 Molecular Chaperones Human genes 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- CAHGCLMLTWQZNJ-UHFFFAOYSA-N Nerifoliol Natural products CC12CCC(O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C)CCC21C CAHGCLMLTWQZNJ-UHFFFAOYSA-N 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- 108010038807 Oligopeptides Proteins 0.000 description 1
- 102000015636 Oligopeptides Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 102000003992 Peroxidases Human genes 0.000 description 1
- 108090000216 Phospholipid Transfer Proteins Proteins 0.000 description 1
- 102000003867 Phospholipid Transfer Proteins Human genes 0.000 description 1
- 108010086950 Phosphoribosylanthranilate isomerase Proteins 0.000 description 1
- 101710173432 Phytoene synthase Proteins 0.000 description 1
- 229940124158 Protease/peptidase inhibitor Drugs 0.000 description 1
- LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 description 1
- 239000012722 SDS sample buffer Substances 0.000 description 1
- 101150014136 SUC2 gene Proteins 0.000 description 1
- 108010051611 Signal Recognition Particle Proteins 0.000 description 1
- 102000013598 Signal recognition particle Human genes 0.000 description 1
- 101710126391 Sucrose transport protein Proteins 0.000 description 1
- 241001000247 Xanthophyllomyces Species 0.000 description 1
- HFYBTHCYPKEDQQ-UHFFFAOYSA-N [2,3-dihydroxy-3-(1h-imidazol-5-yl)propyl] dihydrogen phosphate Chemical compound OP(=O)(O)OCC(O)C(O)C1=CN=CN1 HFYBTHCYPKEDQQ-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000001260 acyclic compounds Chemical class 0.000 description 1
- 101150063416 add gene Proteins 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- LDHQLWOKXNHSSJ-ICWQEWPPSA-N azane;[(2e)-3,7-dimethylocta-2,6-dienyl] phosphono hydrogen phosphate Chemical compound N.N.N.CC(C)=CCC\C(C)=C\COP(O)(=O)OP(O)(O)=O LDHQLWOKXNHSSJ-ICWQEWPPSA-N 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 235000019519 canola oil Nutrition 0.000 description 1
- 239000000828 canola oil Substances 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 239000008004 cell lysis buffer Substances 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 101150081158 crtB gene Proteins 0.000 description 1
- 101150085103 crtY gene Proteins 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 150000001923 cyclic compounds Chemical class 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 230000001086 cytosolic effect Effects 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- QBSJHOGDIUQWTH-UHFFFAOYSA-N dihydrolanosterol Natural products CC(C)CCCC(C)C1CCC2(C)C3=C(CCC12C)C4(C)CCC(C)(O)C(C)(C)C4CC3 QBSJHOGDIUQWTH-UHFFFAOYSA-N 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 229930004069 diterpene Natural products 0.000 description 1
- 150000004141 diterpene derivatives Chemical class 0.000 description 1
- 238000004520 electroporation Methods 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 210000001723 extracellular space Anatomy 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 238000012224 gene deletion Methods 0.000 description 1
- 238000003144 genetic modification method Methods 0.000 description 1
- 238000010362 genome editing Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229930195712 glutamate Natural products 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 230000001146 hypoxic effect Effects 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- CAHGCLMLTWQZNJ-RGEKOYMOSA-N lanosterol Chemical compound C([C@]12C)C[C@@H](O)C(C)(C)[C@H]1CCC1=C2CC[C@]2(C)[C@H]([C@H](CCC=C(C)C)C)CC[C@@]21C CAHGCLMLTWQZNJ-RGEKOYMOSA-N 0.000 description 1
- 229940058690 lanosterol Drugs 0.000 description 1
- 108060004506 lycopene beta-cyclase Proteins 0.000 description 1
- 230000002934 lysing effect Effects 0.000 description 1
- 210000004962 mammalian cell Anatomy 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 229930003658 monoterpene Natural products 0.000 description 1
- 150000002773 monoterpene derivatives Chemical class 0.000 description 1
- 235000002577 monoterpenes Nutrition 0.000 description 1
- 229910017464 nitrogen compound Inorganic materials 0.000 description 1
- 150000002830 nitrogen compounds Chemical class 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 150000002897 organic nitrogen compounds Chemical class 0.000 description 1
- 239000000137 peptide hydrolase inhibitor Substances 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- 108010001545 phytoene dehydrogenase Proteins 0.000 description 1
- 230000004481 post-translational protein modification Effects 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000010814 radioimmunoprecipitation assay Methods 0.000 description 1
- 230000022532 regulation of transcription, DNA-dependent Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 210000004739 secretory vesicle Anatomy 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229930004725 sesquiterpene Natural products 0.000 description 1
- 150000004354 sesquiterpene derivatives Chemical class 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 238000004088 simulation Methods 0.000 description 1
- 235000020183 skimmed milk Nutrition 0.000 description 1
- YYGNTYWPHWGJRM-AAJYLUCBSA-N squalene group Chemical group CC(C)=CCC\C(\C)=C\CC\C(\C)=C\CC\C=C(/C)\CC\C=C(/C)\CCC=C(C)C YYGNTYWPHWGJRM-AAJYLUCBSA-N 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 150000003535 tetraterpenes Chemical class 0.000 description 1
- 235000009657 tetraterpenes Nutrition 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 230000005026 transcription initiation Effects 0.000 description 1
- 238000010361 transduction Methods 0.000 description 1
- 230000026683 transduction Effects 0.000 description 1
- 238000001890 transfection Methods 0.000 description 1
- 238000011426 transformation method Methods 0.000 description 1
- 210000003956 transport vesicle Anatomy 0.000 description 1
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 108010087967 type I signal peptidase Proteins 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/37—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
- C07K14/39—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P5/00—Preparation of hydrocarbons or halogenated hydrocarbons
- C12P5/007—Preparation of hydrocarbons or halogenated hydrocarbons containing one or more isoprene units, i.e. terpenes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
- C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
- C12P1/02—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using fungi
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P23/00—Preparation of compounds containing a cyclohexene ring having an unsaturated side chain containing at least ten carbon atoms bound by conjugated double bonds, e.g. carotenes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/02—Preparation of oxygen-containing organic compounds containing a hydroxy group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/036—Fusion polypeptide containing a localisation/targetting motif targeting to the medium outside of the cell, e.g. type III secretion
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/645—Fungi ; Processes using fungi
- C12R2001/85—Saccharomyces
Definitions
- It relates to a recombinant microorganism comprising a polynucleotide encoding a target product binding protein fused to a secretion signal sequence, a composition comprising the same, and a method for producing a target product using the same.
- One aspect provides a recombinant microorganism comprising a polynucleotide encoding a target product binding protein fused to a secretion signal sequence.
- compositions for use in producing a target product comprising a recombinant microorganism comprising a polynucleotide encoding a target product binding protein fused to the secretion signal sequence and a carrier.
- Another aspect provides a method for producing a target product, comprising culturing a recombinant microorganism comprising a polynucleotide encoding a target product binding protein fused to a secretion signal sequence in a medium.
- One aspect provides a recombinant microorganism comprising a polynucleotide encoding a target product binding protein fused to a secretion signal sequence.
- the polynucleotide may exist outside the genome or genome of the recombinant microorganism.
- the polynucleotide may be operably linked to a regulatory sequence.
- the regulatory sequence may be a sequence necessary for biosynthesis or production of the protein from the polynucleotide.
- the control sequence may be a transcription control sequence, a translation control sequence, and a post-translational modification control sequence.
- the regulatory sequence may be a promoter, an operator, a terminator, an enhancer, a ribosome binding site, or a combination thereof.
- the control sequence may be an endogenous or exogenous control sequence before the recombinant microorganism is recombined.
- the control sequence may be a control sequence of a gene encoding a naked target product binding protein to which the secretion signal sequence is not fused, or a control sequence of a gene encoding a different protein.
- the polynucleotide may be included in the cell in multiple copies.
- the polynucleotide is, for example, 2 or more, 5 or more, 10 or more, 50 or more, 100 or more, 2 to 1000, 2 to 500, 2 to 100, 2 to 50, 2 to 10, 2 to 5, 5 to 100 , 5 to 50, 5 to 10, 5 to 100, 5 to 10, 10 to 100, or 10 to 50 copies may be included in the cell.
- the polynucleotide may be expressed so as to be linked to the control sequence.
- the polynucleotide may be linked to a regulatory sequence that allows it to be expressed at an increased level compared to the expression of the endogenous polynucleotide.
- the polynucleotide may be linked to a promoter having a stronger transcription initiation ability than an endogenous promoter.
- the polynucleotide may also include a nucleotide sequence encoding a tag sequence for use in isolating the extracellularly secreted complex or dissociated target product binding protein.
- the tag sequence may be an oligopeptide.
- the tag sequence may include two or more amino acids, for example, 2 to 50, 2 to 30, 2 to 20, 2 to 15, or 2 to 10 amino acid sequences.
- the tag sequence may be, for example, a His tag sequence.
- the His tag may be linked to the N-terminus or C-terminus of the target product binding protein.
- the tag may be 6xHis.
- the polynucleotide may encode an amino acid sequence in which a secretion signal sequence is fused to the N-terminus of the target product binding protein.
- the polynucleotide may be introduced into a microbial cell before recombination by a genetic modification method known in the art.
- the genetic modification may be by transformation, transduction, transfection, or electroporation.
- the polynucleotide may be generated by gene editing of a gene in a microbial cell prior to recombination.
- the gene correction may be performed by a known method such as clustered regularly interspaced short palindromic repeats (CRISPR) gene correction.
- CRISPR clustered regularly interspaced short palindromic repeats
- the recombinant microorganism may have the ability to secrete a target product binding protein fused to the secretion signal sequence.
- the recombinant microorganism may have the ability to produce the target product.
- the recombinant microorganism may have an increased target product production capacity.
- the recombinant microorganism may be one capable of extracellular secretion in the form of a complex in which the target product and the target product-binding protein are bound. Formation of the complex may be made within a cell. Formation of the complex may be made by cells in the process of cellular metabolism without manipulation from the outside. In the complex, the binding between the target product and the target product-binding protein may be due to non-covalent bonding.
- the non-covalent bond may include a hydrophobic bond, a hydrogen bond, or an ionic bond.
- the complex may be dissociated under conditions suitable for dissociating the bond in a liquid medium to form a dissociated target product and the target product-binding protein, respectively.
- the target product binding protein that is not fused to the secretion signal sequence may exist in a cell, for example, in the cytoplasm in a natural host cell, and thus may not be secreted out of the cell.
- the target product binding protein that is not fused to the secretion signal sequence may not be linked to the secretion signal sequence in a native host cell.
- the target product may be a metabolite.
- the metabolite may be an endogenous metabolite or a metabolite synthesized by its synthetic pathway introduced by genetic modification.
- the metabolite may be a lipid, a polysaccharide, a protein, or a small molecule compound.
- the target product may be a lipid.
- the lipid may be a terpenoid.
- the term "terpenoid" may be a compound synthesized using isoprene as a unit. The terpenoid has 5 to 100, 10 to 100, 15 to 100, 30 to 100, 5 to 60, 10 to 60, 15 to 60, 30 to 60, 5 to 45, 10 to 45, 15 to 45 carbon atoms.
- the terpenoid may include molecular oxygen.
- the terpenoid may be a hydrocarbon that does not contain molecular oxygen.
- the terpenoid may be monoterpene, diterpene, sesquiterpene, triterpene, or tetraterpene.
- the terpenoid may be a cyclic or acyclic compound.
- the terpenoids are the following 43 compounds, namely 2,3-oxidosqualene, myrcene, (z)-ocimene, linalool, geraniol, nerol, limonene, menthol, ⁇ -pinene, camphor, carvacrol, carvone, ⁇ -farnesene, nerolidol , ⁇ -bisabolene, valencene, amorphadiene, capsidiol, ⁇ -cedrane, artemisinin, phytane, phytol, camphorene, retinol, labdane, clerodane, pimarane, abietane, tigolliane, kaurane, taxane, ⁇ -amyrin, ⁇ -amyrin, ⁇ -amyrin , hopane, oleanolic acid, lycopene, rubixanthin, ⁇ -carotene, lutein,
- the target product may be squalene or beta-carotene.
- the recombinant microorganism may have an enhanced terpenoid biosynthesis pathway.
- the recombinant microorganism may have an enhanced biosynthetic pathway of one or more of the 43 compounds.
- the target product binding protein may bind to the metabolite.
- the target product binding protein may specifically bind to the metabolite.
- the target product binding protein may be a lipid binding protein.
- the target product binding protein may be a cytoplasmic lipid binding protein.
- the lipid binding protein is a supernatant protein factor (SPF), phosphatidylinositol transfer protein (Sec14), alpha-tocopherol transfer protein (alpha-tocopherol transfer protein, TTP), cellular retinal binding protein ( It may be selected from the group consisting of cellular retinal binding protein), squid retinal binding protein, or a fragment thereof having a target product binding ability.
- the lipid binding protein may be of any cell origin.
- the lipid binding protein may be derived from a mammalian cell.
- the SPF and TTP may be derived from humans or mice.
- Human-derived SPF has a 403 amino acid sequence, and has an N-terminal domain having lipid-binding ability and a C-terminal domain having a jelly-roll motif, that is, a Golgi dynamics domain (GOLD).
- GOLD Golgi dynamics domain
- SPF may be a truncated SPF (tSPF) having squalene-binding ability and in which the C-terminal domain, ie, amino acid sequences 276 to 403 are cleaved and removed. That is, tSPF may consist of amino acid sequences 1 to 275 of SPF.
- SPF and tSPF may have amino acid sequences of SEQ ID NOs: 1 and 2, respectively.
- the nucleotides encoding SPF and tSPF may have the nucleotide sequences of SEQ ID NOs: 3
- the secretion signal sequence represents an amino acid sequence for extracellular secretion of a protein expressed in a cell.
- the secretion signal sequence may be a secretion signal sequence derived from a eukaryotic cell or a prokaryotic cell.
- the secretion signal sequence may be any amino acid sequence capable of extracellular secretion of the target product binding protein in the recombinant microorganism.
- the secretion signal sequence may be derived from the same or a different cell from the recombinant microbial cell.
- the secretion signal sequence may be an animal, plant, yeast, or bacterial-derived secretion signal sequence.
- the secretion signal sequence may be at least one selected from the group consisting of Suc2, Pho5, MF ⁇ , Inu1, and Mel1 secretion signal sequence.
- the Suc2, Pho5, and MF ⁇ secretion signal sequences may have the amino acid sequences of SEQ ID NOs: 5, 6 and 7, respectively.
- the nucleotides encoding the Suc2, Pho5, and MF ⁇ secretion signal sequences may have the nucleotide sequences of SEQ ID NOs: 8, 9, and 10.
- the recombinant microorganism may be a eukaryotic cell or a prokaryotic cell.
- the eukaryotic cell may be an animal, plant, or fungal cell.
- the fungus may be yeast.
- the yeast cell may be of the genus Saccharomyces.
- the cell of the genus Saccharomyces may be Saccharomyces cerevisiae.
- the prokaryotic cell may be a bacterium.
- the bacteria may belong to the genus Escherichia , the genus Corynebacterium , or the genus Bacillus .
- the bacteria may be lactic acid bacteria, for example, Lctobacillus , or belonging to the genus Lactococcus .
- the bacteria may be Escherichia coli , Corynebacterium glutamicum , or Bacillus subtilus .
- the recombinant microorganism may be a genetic modification that increases the expression of a polynucleotide encoding a target product or an enhanced metabolic pathway for producing the target product.
- the recombinant microorganism may have an increased target product-producing ability compared to the cells before transformation.
- the genetic modification may be an increase in the number of copies of the polynucleotide encoding the target product.
- the genetic modification may be a modification of a regulatory sequence that increases the expression of a polynucleotide encoding a target product.
- the recombinant microorganism may have an enhanced metabolic pathway for producing a target product.
- the metabolic pathway for producing the target product may be enhanced by genetic modification to increase the expression of a polynucleotide encoding a factor such as a protein or enzyme involved in the biosynthesis of the target product.
- the genetic modification may be an increase in the number of copies of a polynucleotide encoding a factor such as a protein or enzyme involved in the biosynthesis of a target product or modification of a regulatory sequence thereof.
- the recombinant microorganism may also have a weakened metabolic pathway that inhibits the production of the target product.
- the metabolic pathway may be, for example, a pathway that degrades a target product or a feedback inhibition pathway.
- the target product binding protein may be SPF or a ligand binding fragment thereof.
- the target product binding protein is L84, I103, L106, A108, L111, L112, L120, L121, K124, I151, Y153, C155, L158, H162, A167, V168, A170, Y171 in the amino acid sequence of SPF of SEQ ID NO: 1. , F174, L175, L186, L189, F198, A201, Y202, I205, L209, T213, and I217 amino acids.
- the recombinant microorganism may be of the genus Saccharomyces , for example, Saccharomyces cerevisiae .
- the recombinant microorganism may have enhanced mevalonic acid biosynthetic pathway or beta-carotene biosynthetic pathway.
- the recombinant microorganism may include a genetic modification that increases the activity of one or more of HMG-CoA and ERG20.
- the recombinant microorganism may include a genetic modification that increases the expression of a gene encoding HMG-CoA or ERG20.
- the genetic modification may be an increase in the copy number of the gene.
- the recombinant microorganism may be inactivated at least one of trp1, leu2, his3, and yp1062w. It includes not only completely eliminating but also reducing the expression of the inactivated gene.
- the inactivation may be a deletion of one or more genes among trp1, leu2, his3 and yp1062w.
- HMG-CoA, ERG20, trp1, leu2, his3 and yp1062w may have the amino acid sequences of SEQ ID NOs: 11, 12, 13, 14, 15, and 16, respectively.
- the HMG-CoA, ERG20, trp1, leu2, his3 and yp1062w genes may have the nucleotide sequences of SEQ ID NOs: 17, 18, 19, 20, 21, and 22.
- FIG. 1 is a diagram schematically illustrating a process of secreting squalene from yeast cells containing a polynucleotide encoding a Suc2-tSPF fusion protein.
- a signal peptide located at the N-terminus is bound to a signal recognition particle, and the partially translated complex of the fusion protein and ribosome is transferred to the endoplasmic reticulum membrane.
- step A When the nascent polypeptide of the fusion protein is synthesized in the ER and the signal peptide is cleaved by signal peptidase in the ER lumen, only tSPF, i.e., the polypeptide of the target product binding protein, remains (step A).
- the polypeptide of the binding protein can be further modified by the endoplasmic reticulum chaperone protein, which then forms a mature protein (step B).
- step B The mature squalene-specific binding protein forms a complex by specific binding with squalene accumulated in the cell. This process captures the target metabolite (step C).
- the complex encapsulated by the transport vesicle can be transported to the Golgi apparatus (step D).
- Complexes of squalene and binding proteins can be released into the extracellular space by secretory vesicles in the Golgi apparatus (step E).
- compositions for use in producing a target product comprising a recombinant microorganism comprising a polynucleotide encoding a target product binding protein fused to the secretion signal sequence and a carrier.
- a recombinant microorganism comprising a polynucleotide encoding a target product binding protein fused to a secretion signal sequence is as described above.
- the carrier may be a medium, buffer, or stock solution used for culturing the microorganism.
- Another aspect provides a method for producing a target product, comprising culturing a recombinant microorganism comprising a polynucleotide encoding a target product binding protein fused to a secretion signal sequence in a medium.
- a recombinant microorganism comprising a polynucleotide encoding a target product binding protein fused to a secretion signal sequence is as described above.
- the culturing includes incubating a mixture comprising the recombinant microorganism and the medium under conditions suitable for the recombinant microorganism to grow and to produce a target product binding protein fused to the secretion signal sequence.
- the culture may be performed in a medium containing a carbon source, for example, glucose.
- a carbon source for example, glucose.
- the medium used for culturing the microorganism may be any conventional medium suitable for growth of the selected recombinant cells, such as minimal or complex medium with appropriate supplements. Suitable media are available from commercial vendors or can be prepared according to known recipes.
- the medium may be a medium capable of satisfying the requirements of a specific microorganism according to the selected target product.
- the medium may include a component selected from the group consisting of a carbon source, a nitrogen source, a salt, a trace element, and combinations thereof.
- the conditions of the culture may be appropriately adjusted for the production of a selected target product, for example, a terpenoid such as squalene.
- the culture may be performed under aerobic conditions for cell proliferation.
- the incubation may be performed without or with agitation.
- the culture may be a batch, a fed batch, or a continuous culture.
- the continuous culture may be a continuous culture while replenishing the medium while removing a portion of the microorganism or supernatant from the culture.
- the recombinant microorganism can secrete the target product extracellularly in the form of a complex with the target product-binding protein, and can be separated from the supernatant from which the cells are removed from the culture.
- the culturing may be culturing in a medium containing a compound having high solubility for the target product.
- the solubility may be higher than that of the medium or water.
- the solubility is at least 1.2, 1.5, 2.0, 3.0, 5.0, 7.5, or 10 times, or 1.2 to 10, 1.5 to 10, 2.0 to 10, 3.0 to 10, 5.0 to 10, or 7.5 to 10 compared to the medium or water. It may have the solubility of a ship.
- the target product may be a lipid, for example, a terpenoid
- the compound having high solubility for the target product may be an oily compound having high solubility for a lipid, for example, a terpenoid.
- the target product is extracellularly secreted in the form of a target product-target product binding protein complex during culture, and in the extracellular medium, the complex is dissociated into the target product and the target product binding protein and the complex is in a dynamic equilibrium state may exist. Accordingly, a portion of the target product dissociated in the dynamic equilibrium state may be distributed to the compound layer having high solubility for the target product.
- the target product is a lipid, for example, a terpenoid
- the culture is performed in a medium containing an oily compound
- the target product is secreted out of the cell and then distributed to the oily compound layer in the medium.
- the oily compound may be an alkane solvent, for example, a C1 to C60, C6 to C60, or C3 to C30 alkane.
- the solvent may be hexane, heptane, decane, dodecane, or hexadecane.
- the oily compound may be a vegetable oil.
- the vegetable oil may be olive oil, canola oil, or essential oil.
- the oily compound may be a compound that is easy to separate from each other due to a large difference in boiling point from the target product,
- culture conditions means conditions for culturing microorganisms.
- Such culture conditions may be, for example, a carbon source, a nitrogen source, or an oxygen condition used by the microorganism.
- Carbon sources available to yeast may include monosaccharides, disaccharides or polysaccharides.
- the carbon source is a magnetizable sugar and may include glucose, fructose, mannose, or galactose.
- the nitrogen source may be an organic nitrogen compound or an inorganic nitrogen compound.
- the nitrogen source may be an amino acid, an amide, an amine, a nitrate, or an ammonium salt.
- the oxygen conditions for culturing microorganisms include aerobic conditions of normal oxygen partial pressure, hypoxic conditions containing 0.1% to 10% of oxygen in the atmosphere, or anaerobic conditions without oxygen.
- the method may include isolating the target product.
- the step of isolating the target product may not include the step of disrupting cells.
- Separating the target product may include separating the supernatant from the culture.
- the separating may include separating the target product from the supernatant.
- Separating the target product may include separating the target product from the complex of the target product and the target product-binding protein.
- the culture or supernatant containing the complex is incubated in a liquid medium under conditions suitable for dissociating the complex into the target product and the target product-binding protein. include that The conditions may be appropriately selected depending on the target product and target product-binding protein to be selected.
- the target product is a terpenoid compound such as squalene or beta-carotene
- the separating may include incubating the complex in a hydrophobic solvent, for example, an oily compound.
- the solvent may be an alkane, for example, a C1 to C60, C6 to C60, or C3 to C30 alkane.
- the solvent may be hexane, heptane, decane, dodecane, or hexadecane.
- the separating step may be performed simultaneously with the culture.
- the target product is 2,3-oxidosqualene, myrcene, (z)-ocimene, linalool, geraniol, nerol, limonene, menthol, ⁇ -pinene, camphor, carvacrol, carvone, ⁇ -farnesene, nerolidol, ⁇ -bisabolene, valencene, amorphadiene, capsidiol, ⁇ -cedrane, artemisinin, phytane, phytol, camphorene, retinol, labdane, clerodane, pimarane, abietane, tigliane, kaurane, taxane, squalene, hoposterane, ⁇ -amyrin, ⁇ -amyrin, , oleanolic acid, lycopene, rubixanthin, ⁇ -carotene, lutein, zeaxanthin,
- the target product binding protein may be selected from the group consisting of SPF, Sec14, TTP, alpha-tocopherol transfer protein, cellular retinal binding protein, squid retinal binding protein, or a fragment thereof having a target product binding ability.
- the recombinant microorganism may be a yeast cell, for example, of the genus Saccharomyces .
- the microorganism of the genus Saccharomyces may be S. cerevisiae .
- Recombinant microorganisms according to an aspect can be used to efficiently produce a target product.
- composition for use in producing a target product according to an aspect may be used to efficiently produce a target product.
- the target product can be efficiently produced.
- FIG. 1 is a diagram schematically illustrating a process of secreting squalene from yeast cells containing a polynucleotide encoding a Suc2-tSPF fusion protein.
- Figure 2a is a diagram showing the extracellular squalene concentration produced by yeast cells comprising a polynucleotide encoding tSPF fused to a secretion signal sequence.
- 2B is a diagram showing the intracellular squalene concentration produced by yeast cells containing a polynucleotide encoding tSPF fused to a secretion signal sequence.
- FIG. 3 is a diagram showing the results of HPLC analysis of squalene secreted by SQ strains each transformed with Suc2-tSPF, Pho5-tSPF and MF ⁇ -tSPF fusion protein genes.
- FIG. 4 is a view showing the results of culturing SQ strains transformed with Suc2-tSPF, Pho5-tSPF, and MF ⁇ -tSPF fusion protein genes, respectively, and Western blot analysis of cell lysates and culture supernatant.
- Figure 5 shows the amount of beta-carotene produced by culturing CEN.PK2-1D yeast cells co-transformed with p415-BC vector and pSEC-tSPF or pSEC-Suc2-tSPF.
- FIG. 6 is a view showing the results of HPLC analysis of extracellularly secreted beta-carotene produced by yeast cells transformed with the Suc2-tSPF fusion protein gene.
- Example 1 Yeast cells with increased squalene secretion and squalene production using same
- a recombinant yeast cell was prepared by introducing a target product binding protein fused to a secretion signal sequence into a yeast cell, and a target product was produced using the prepared recombinant yeast cell, and the secretory ability thereof was confirmed.
- Yeast cells were Saccharomyces cerevisiae, and secretion signal sequences Suc2, Pho5, and MF ⁇ secretion signal sequences were used, respectively.
- squalene was used as the target product
- tSPF a cleaved fragment of SPF
- tSPF is a squalene-binding protein corresponding to the N-terminal domain having lipid-binding ability of supernatant protein factor (SPF).
- SPF supernatant protein factor
- tSPF corresponds to amino acid sequences 1 to 275 in SPF having the amino acid sequence of SEQ ID NO: 1.
- Yeast cells were Saccharomyces cerevisiae , and wild-type strain CEN.PK2-1D [( MAT ⁇ ura3-52; trp1-289; leu2-3,112; his3 ⁇ 1; MAL2-8; SUC2 ) (EUROSCARF accession number: 30000B) was used.
- the strain is phosphoribosylanthranilate isomerase (trp1), 3-isopropylmalate dehydrogenase (3-isopropylmalate dehydrogenase, leu2) and imidazoleglycerol-phosphate dehydratase (imidazoleglycerol-phosphate)
- the gene encoding dehydratase, his3) is inactivated.
- trp1, leu2, and his3 may have the amino acid sequences of SEQ ID NOs: 13, 14, and 15, respectively.
- the trp1, leu2, and his3 genes may have the nucleotide sequences of SEQ ID NOs: 19, 20, and 21, respectively.
- Squalene is a terpenoid and is synthesized through the mevalonic acid biosynthesis pathway in yeast cells. The following genetic modifications were introduced to increase the ability to produce squalene.
- the tHMG1 gene encoding S. cerevisiae -derived HMG-CoA reductase ( ⁇ -Hydroxy ⁇ -methylglutaryl-CoA reductase) and S. cerevisiae -derived farnesyl pyrophosphate synthase are located in the deleted trp1, leu2 and his3 gene positions of the strain.
- a gene encoding farnesyl pyrophosphate synthetase (ERG20) was introduced.
- tHMG1 and ERG20 may have the amino acid sequences of SEQ ID NOs: 11 and 12, respectively.
- the tHMG1 and ERG20 genes may have the nucleotide sequences of SEQ ID NOs: 17 and 18, respectively.
- HMG-CoA reductase is an enzyme that catalyzes the conversion of HMG-CoA to mevalonate.
- ERG20 is an enzyme that catalyzes the conversion of GPP to FPP. Both HMG-CoA and FPP are precursors for squalene synthesis.
- ypl062w was deleted in the genome of the strain, and the tHMG1 gene was introduced into the ypl062w site.
- the ypl062w gene deletion may increase the level of acetyl-CoA, an initial substrate of the mevaloic acid biosynthetic pathway.
- ypl062w may have the amino acid sequence of SEQ ID NO: 16.
- the ypl062w gene may have the nucleotide sequence of SEQ ID NO: 22.
- tSPF was used for the squalene binding protein.
- a polynucleotide encoding a fusion protein was obtained in which three different signal peptides, namely, Suc2, Pho5, and MF ⁇ signal peptide, were fused to the N-terminus of tSPF, respectively.
- the fusion protein contains a 6xHis tag sequence at the C terminus.
- the Suc2, Pho5, and MF ⁇ signal peptides may have the amino acid sequences of SEQ ID NOs: 5, 6 and 7, respectively.
- the nucleotides encoding the Suc2, Pho5, and MF ⁇ signal peptides may have the nucleotide sequences of SEQ ID NOs: 8, 9, and 10.
- Suc2, Pho5, and MF ⁇ signal peptides function as an N-terminal signal peptide to extracellularly secrete sucrose transport protein (Suc2), acid phosphatase (Pho5), and yeast ⁇ -mating factor (MF ⁇ ), respectively.
- Suc2 Pho5, and MF ⁇ signal peptides function as an N-terminal signal peptide to extracellularly secrete sucrose transport protein (Suc2), acid phosphatase (Pho5), and yeast ⁇ -mating factor (MF ⁇ ), respectively.
- is an amino acid sequence with tSPF has the amino acid sequence of SEQ ID NO:2.
- tSPF
- the obtained Suc2-tSPF, Pho5-tSPF, and MF ⁇ -tSPF fusion proteins may have the amino acid sequences of SEQ ID NOs: 23, 24 and 25, respectively.
- the nucleotides encoding the Suc2-tSPF, Pho5-tSPF, and MF ⁇ -tSPF fusion proteins may have the nucleotide sequences of SEQ ID NOs: 26, 27, and 28.
- the polynucleotide was introduced into the SpeI/XhoI restriction enzyme site of the p426-TEF1 (SEQ ID NO: 29) vector to obtain expression vectors pSEC-Suc2-tSPF, pSEC-Pho5-tSPF and pSEC-MF ⁇ -tSPF.
- pSEC-tSPF vector in which a tSPF gene without a secretion signal sequence was introduced into p426-TEF1, and an empty p426-TEF1 vector were used.
- p426-TEF1 is a high copy number plasmid containing the TEF1 promoter.
- the fusion protein is operably linked by a TEF1 promoter, whereby transcription can be initiated.
- the expression vector was introduced into the SQ strain by a heat shock transformation method to obtain an SQ strain transformed with three types of fusion protein genes, respectively.
- the expression vector exists independently of the genome of the SQ strain.
- the SQ strain transformed with pSEC-Suc2-tSPF, pSEC-Pho5-tSPF and pSEC-MF ⁇ -tSPF was transformed into YSC medium supplemented with 2% (w/v) glucose and 10% (v/v) dodecane; 250 containing 0.67% (w/v) yeast nitrogen base without amino acids (BD Difco, USA), 0.19% (w/v) yeast synthetic drop-out medium supplements without uracil (Sigma-Aldrich, USA)) 50 mL It was incubated at 30° C. while stirring at 250 rpm in an L flask.
- the culture was centrifuged at 4,000 rpm to separate cells, culture supernatant and dodecane layer.
- concentration of squalene in the isolated cells and dodecane layer was measured.
- the cells are resuspended in 600 ⁇ L of a 1:1 mixture of methanol and acetone, transferred to a tube containing lysing matrix C (glass bead, MP Biomedicals, USA), and placed in a FastPrep-24 5G homogenizer ( Cells were disrupted using MP Biomedicals, USA) and centrifuged at 13,000 rpm to separate the disrupted cells and intracellular metabolites including squalene dissolved from the disrupted cells.
- lysing matrix C glass bead, MP Biomedicals, USA
- the squalene concentration of the cell lysate was measured.
- it was filtered with a 0.2 ⁇ m syringe filter, and then the concentration was measured using the Agilent HPLC system.
- Table 1 shows the intracellular and extracellular squalene concentrations produced by yeast cells containing a polynucleotide encoding tSPF fused to a secretion signal sequence.
- 2A and 2B show the extracellular and intracellular squalene concentrations produced by yeast cells comprising a polynucleotide encoding tSPF fused to a secretion signal sequence, respectively.
- FIG. 3 is a view showing the results of HPLC analysis of squalene produced by the SQ strain transformed with the Suc2-tSPF, Pho5-tSPF, and MF ⁇ -tSPF fusion protein genes and secreted out of the cell, respectively.
- the results in FIG. 3 correspond to the extracellularly secreted squalene data in Table 1.
- FIG. 4 is a view showing the results of Western blot analysis of the cell lysate and culture supernatant obtained by culturing the SQ strain transformed with the Suc2-tSPF, Pho5-tSPF and MF ⁇ -tSPF fusion protein genes, respectively.
- yeast cells were incubated for 2 days in 50 ml of YSC medium containing 2% (w/v) glucose (YSC medium; 0.67% (w/v) yeast nitrogen base without amino acids ( BD Difco, USA) and 0.19% (w/v) yeast synthetic drop-out medium supplements without uracil (Sigma-Aldrich, USA)) were cultured in a 250 mL flask with stirring at 30°C. At this time, the minimal medium did not contain a dodecane layer.
- YSC medium 2% (w/v) glucose
- yeast nitrogen base without amino acids
- yeast synthetic drop-out medium supplements without uracil Sigma-Aldrich, USA
- the precipitated protein was washed 3 times with 1 ml of cold acetone and resuspended in 50 ⁇ l of sterile water.
- the resuspended protein was further concentrated using 30 kDa amicon ultra centrifugal filters.
- the prepared protein sample ie, cell lysate
- 5x SDS sample buffer was mixed with 5x SDS sample buffer and separated by 10% SDS-PAGE. Proteins separated from the SDS-PAGE gel were transferred to a PVDF membrane, and then blocked by incubation in TBST containing 4% skim milk for one day.
- the PVDF membrane was reacted with a solution containing the primary antibody at room temperature for 1 hour, and then washed three times with a TBST solution.
- As the primary antibody an anti-actin antibody or an anti-His tag antibody was used.
- the fusion protein contains a 6xHis tag sequence at the C terminus.
- the washed PVDF membrane was reacted again with a solution containing peroxidase-conjugated anti-IgG antibody at room temperature for 1 hour.
- the PVDF membrane with the antibody-bound protein was visualized using the ChemiDoc imaging system.
- FIG. 5 Western blot results are shown in FIG. 5 .
- the bands of Suc2-tSPF and Pho5-tSPF hardly appeared, so the tSPF fused to the secretion signal sequence did not stay inside the cell but moved outside the cell.
- tSPF not fused to the secretion signal sequence did not migrate to the outside of the cell when the secretion signal sequence was not fused, as a clear band appeared in the cell lysate.
- tSPF not fused to the secretion signal sequence did not show a band. This indicates that tSPF not fused to the secretory signal sequence does not migrate extracellularly.
- Example 2 Yeast cells with increased beta-carotene secretion and beta-carotene production using the same
- a vector containing a beta-carotene biosynthesis gene was introduced into the CEN.PK2-1D yeast strain described in Section 1.1 of Example 1 to prepare yeast cells with increased beta-carotene-producing ability.
- the crtE, crtYB, crtI and tHMG1 genes were amplified from the pMM494 vector (Addgene, Plasmid #100539) containing the expression cassettes of crtE, crtYB, crtI and tHMG1 of the beta-carotene biosynthetic pathway, and the p415-GPD vector ( SEQ ID NO: 30) was introduced into the site of restriction enzymes BamHI and SalI to construct a p415-BC vector containing expression cassettes for crtE, crtYB, crtI and tHMG1.
- the p415-GPD vector (ATCC 87358) is a low copy number expression vector containing the GPD1 promoter.
- crtE, crtYB, and crt have the amino acid sequences of SEQ ID NOs: 31, 32 and 33, respectively.
- the polynucleotides encoding crtE, crtYB, and crt have the nucleotide sequences of SEQ ID NOs: 34, 35 and 36, respectively.
- the crtE, crtYB, and crtI proteins are proteins derived from Xanthophyllomyces dendrohous and have the following activities.
- crtE is a gene encoding geranylgeranyl diphosphate that catalyzes the conversion of farnesyl diphosphate to geranylgeranyl diphosphate.
- crtYB is crtB, which encodes phytoene synthase, which catalyzes the reaction of converting geranylgeranyl diphosphate to phytoene, and lycopene beta-cyclase, which catalyzes the reaction of converting lycopene to beta-carotene. contains the gene crtY.
- crtI is a gene encoding a phytoene desaturase that converts phytoene into lycopene.
- the p415-BC vector prepared in section (1.2) and pSEC-tSPF or pSEC-Suc2-tSPF were co-transfected into the wild S. cerevisiae strain CEN.PK2-1D.
- a transformed yeast cell was prepared with a vector expressing tSPF fused to a signal peptide by cotransformation.
- CEN.PK2-1D yeast cells capable of over-producing beta-carotene by co-transformation with the p415-BC vector obtained in section (2.2) and pSEC-tSPF or pSEC-Suc2-tSPF were prepared as described in section (1.3) of Example 1 Incubated for 144 hours under the same conditions as the bar, the amount of intracellular and extracellular beta-carotene produced was measured. The amount of beta-carotene was measured by the same method as the cell disruption and dodecane layer separation methods used to measure the squalene concentration.
- Table 2 and Figure 6 show the amount of beta-carotene produced by culturing CEN.PK2-1D yeast cells co-transformed with p415-BC vector and pSEC-tSPF or pSEC-Suc2-tSPF.
- the yeast cells transformed with the Suc2-tSPF fusion protein gene significantly increased the amount of extracellular beta-carotene or the ratio of extracellular secretion compared to the control cells. Specifically, the extracellular secretion of beta-carotene was increased by about 23 times compared to the control group including the empty vector.
- the results of Figure 6 correspond to the beta-carotene secreted extracellularly in Table 2, that is, beta-carotene secreted to the dodecane layer.
- dodecane + 1 ppm beta-carotene and “dodecane + 1 ppm lycopene” are a standard mixture containing 1 ppm beta-carotene in dodecane and 1 ppm lycopene in dodecane as controls, respectively. indicates.
- the three-dimensional crystallographic structure of tSPF (PDB ID: 4OMK) was obtained from the RCSB protein data bank.
- PDB ID: 4OMK the A chain of 4ONK in which squalene and water molecules bound from the crystal structure were removed prior to simulation were used.
- One possible structure was deliberately selected for each amino acid to construct a rigid protein structure in the crystallographic structure, and the squalene-binding active site of the A chain was determined using Computer Atlas of Surface Topology of protein (CASTp).
- the identified residues necessary for squalene binding are L84, I103, L106, A108, L111, L112, L120, L121, K124, I151, Y153, C155, L158, H162, A167, V168, A170, Y171, F174, L175, L186, L189, F198, A201, Y202, I205, L209, T213, and I217. Accordingly, it is believed that the squalene binding site includes these residues.
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Biomedical Technology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
세포 | 72 시간 | 144 시간 | ||||||
세포성장 (OD600) |
세포내 (mg/L) |
세포내 (mg/g) |
세포외 (mg/L) |
세포성장 (OD600) |
세포내 (mg/L) |
세포내 (mg/g) |
세포외 (mg/L) |
|
빈 벡터 | 20.23 | 574.98 | 69.32 | 3.99 | 23.92 | 648.03 | 66.07 | 8.73 |
tSPF | 17.79 | 401.51 | 55.05 | 3.67 | 19.91 | 485.04 | 59.43 | 13.82 |
Suc2-tSPF | 12.98 | 476.9 | 89.61 | 166.62 | 13.87 | 557.03 | 97.93 | 226.51 |
Pho5-tSPF | 11.9 | 252.17 | 51.68 | 64.55 | 14.38 | 426.85 | 72.39 | 190.09 |
MFα-tSPF | 11.44 | 210.52 | 44.88 | 4.21 | 17.16 | 551.64 | 78.42 | 43.25 |
세포 | 144 시간 | |||
세포성장 (OD600) |
세포내 (mg/L) |
세포내 (mg/g) |
세포외 (mg/L) |
|
빈 벡터 | 22.58 | 9.52 | 0.84 | 0.06 |
tSPF | 20.36 | 7.04 | 0.69 | 0.23 |
Suc2-tSPF | 18.66 | 7.65 | 0.82 | 1.4 |
Claims (20)
- 분비 신호서열에 융합된 표적산물 결합 단백질을 코딩하는 폴리뉴클레오티드를 포함하는 재조합 미생물.
- 청구항 1에 있어서, 상기 분비 신호서열에 융합된 표적산물 결합 단백질 분비능을 갖는 것인 재조합 미생물.
- 청구항 1에 있어서, 상기 표적산물 결합 단백질은 리피드 결합 단백질인 것인 재조합 미생물.
- 청구항 3에 있어서, 상기 리피드 결합 단백질은 SPF, Sec14, TTP, 알파-토코페롤 전달 단백질, 세포성 레티날 결합 단백질, 오징어 레티날 결합 단백질, 또는 표적산물 결합능을 갖는 이들의 단편으로 이루어진 군으로부터 선택되는 것인 재조합 미생물.
- 청구항 1에 있어서, 상기 표적산물 생산능이 증가된 것인 재조합 미생물.
- 청구항 1에 있어서, 상기 표적산물은 대사산물인 것인 재조합 미생물.
- 청구항 6에 있어서, 상기 리피드는 테르페노이드 화합물인 것인 재조합 미생물.
- 청구항 1에 있어서, 상기 표적산물은 2,3-oxidosqualene, myrcene, (z)-ocimene, linalool, geraniol, nerol, limonene, menthol, α-pinene, camphor, carvacrol, carvone, β-farnesene, nerolidol, β-bisabolene, valencene, amorphadiene, capsidiol, α-cedrane, artemisinin, phytane, phytol, camphorene, retinol, labdane, clerodane, pimarane, abietane, tigliane, kaurane, taxane, squalene, lanosterol, α-amyrin, β-amyrin, hopane, oleanolic acid, lycopene, rubixanthin, β-carotene, lutein, zeaxanthin, 및 astaxanthin으로 이루어진 군으로부터 선택되는 화합물인 것인 재조합 미생물.
- 청구항 1에 있어서, 상기 분비 신호서열은 Suc2, Pho5, 및 MFα로 이루어진 군으로부터 선택된 하나 이상인 것인 재조합 미생물.
- 청구항 1에 있어서, 표적산물을 코딩하는 폴리뉴클레오티드의 발현을 증가시키는 유전적 변형 또는 표적산물을 생산하는 대사 경로를 강화시키는 유전적 변형을 포함하는 것인 재조합 미생물.
- 청구항 1에 있어서, 효모 세포인 것인 재조합 미생물.
- 청구항 12에 있어서, Saccharomyces 속인 것인 재조합 미생물.
- 청구항 1에 있어서, 상기 표적산물은 2,3-oxidosqualene, myrcene, (z)-ocimene, linalool, geraniol, nerol, limonene, menthol, α-pinene, camphor, carvacrol, carvone, β-farnesene, nerolidol, β-bisabolene, valencene, amorphadiene, capsidiol, α-cedrane, artemisinin, phytane, phytol, camphorene, retinol, labdane, clerodane, pimarane, abietane, tigliane, kaurane, taxane, squalene, lanosterol, α-amyrin, β-amyrin, hopane, oleanolic acid, lycopene, rubixanthin, β-carotene, lutein, zeaxanthin, 및 astaxanthin으로 이루어진 군으로부터 선택되는 화합물이고,상기 표적산물 결합 단백질은 SPF, Sec14, TTP, 알파-토코페롤 전달 단백질, 세포성 레티날 결합 단백질, 오징어 레티날 결합 단백질, 또는 표적산물 결합능을 갖는 이들의 단편으로 이루어진 군으로부터 선택되는 것이고,효모 세포인 것인 재조합 미생물.
- 분비 신호서열에 융합된 표적산물 결합 단백질을 코딩하는 폴리뉴클레오티드를 포함하는 재조합 미생물 및 담체를 포함하는 표적산물을 생산하는데 사용하기 위한 조성물.
- 분비 신호서열에 융합된 표적산물 결합 단백질을 코딩하는 폴리뉴클레오티드를 포함하는 재조합 미생물을 배지 중에서 배양하는 단계를 포함하는 표적산물을 생산하는 방법.
- 청구항 15에 있어서, 상기 배양하는 단계는 배지 또는 물에 대한 표적산물의 용해도에 비하여 표적산물의 용해도가 높은 화합물을 포함하는 배지 중에서 배양하는 단계를 포함하는 것인 방법.
- 청구항 15에 있어서, 상기 표적산물을 분리하는 단계를 포함하고, 상기 표적산물을 분리하는 단계는 배양물로부터 상등액을 분리하는 단계를 포함하는 것인 방법.
- 청구항 17에 있어서, 상기 상등액으로부터 상기 표적산물을 분리하는 단계를 포함하는 것인 방법.
- 청구항 16에 있어서, 배지 또는 물에 대한 표적산물의 용해도에 비하여 표적산물의 용해도가 높은 화합물층으로부터 표적산물을 분리하는 단계를 포함하는 것인 방법.
- 청구항 19에 있어서, 상기 표적산물은 2,3-oxidosqualene, myrcene, (z)-ocimene, linalool, geraniol, nerol, limonene, menthol, α-pinene, camphor, carvacrol, carvone, β-farnesene, nerolidol, β-bisabolene, valencene, amorphadiene, capsidiol, α-cedrane, artemisinin, phytane, phytol, camphorene, retinol, labdane, clerodane, pimarane, abietane, tigliane, kaurane, taxane, squalene, lanosterol, α-amyrin, β-amyrin, hopane, oleanolic acid, lycopene, rubixanthin, β-carotene, lutein, zeaxanthin, 및 astaxanthin으로 이루어진 군으로부터 선택되는 화합물이고,상기 표적산물 결합 단백질은 SPF, Sec14, TTP, 알파-토코페롤 전달 단백질, 세포성 레티날 결합 단백질, 오징어 레티날 결합 단백질, 또는 표적산물 결합능을 갖는 이들의 단편으로 이루어진 군으로부터 선택되는 것이고,상기 재조합 미생물인 효모 세포인 것인 방법.
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP21872679.2A EP4219533A1 (en) | 2020-09-28 | 2021-07-08 | Recombinant microorganism comprising polynucleotide encoding target product binding protein fused to secretion signal sequence, composition comprising same, and method for producing target product by using same |
US18/027,984 US20240002888A1 (en) | 2020-09-28 | 2021-07-08 | Recombinant microorganism comprising polynucleotide encoding target product binding protein fused to secretion signal sequence, composition comprising same, and method for producing target product by using same |
JP2023519309A JP2023543041A (ja) | 2020-09-28 | 2021-07-08 | 分泌シグナル配列に融合された標的産物結合タンパク質をコーディングするポリヌクレオチドを含む組換え微生物、それを含む組成物、及びそれを利用して標的産物を生産する方法 |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR20200125985 | 2020-09-28 | ||
KR10-2020-0125985 | 2020-09-28 | ||
KR1020210037445A KR102625766B1 (ko) | 2020-09-28 | 2021-03-23 | 분비 신호서열에 융합된 표적산물 결합 단백질을 코딩하는 폴리뉴클레오티드를 포함하는 재조합 미생물, 그를 포함하는 조성물 및 그를 이용하여 표적산물을 생산하는 방법 |
KR10-2021-0037445 | 2021-03-23 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2022065643A1 true WO2022065643A1 (ko) | 2022-03-31 |
Family
ID=80846758
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/KR2021/008714 WO2022065643A1 (ko) | 2020-09-28 | 2021-07-08 | 분비 신호서열에 융합된 표적산물 결합 단백질을 코딩하는 폴리뉴클레오티드를 포함하는 재조합 미생물, 그를 포함하는 조성물 및 그를 이용하여 표적산물을 생산하는 방법 |
Country Status (4)
Country | Link |
---|---|
US (1) | US20240002888A1 (ko) |
EP (1) | EP4219533A1 (ko) |
JP (1) | JP2023543041A (ko) |
WO (1) | WO2022065643A1 (ko) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2023227815A1 (es) * | 2022-05-24 | 2023-11-30 | Universitat Politècnica De València | Levadura y plásmido para la exposición de proteínas en superficie |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5726044A (en) * | 1994-09-14 | 1998-03-10 | Fuji Immunopharmaceuticals Corp. | Expression and export technology of proteins as immunofusins |
KR20070079025A (ko) * | 2006-01-31 | 2007-08-03 | 대한민국(관리부서:국립수산과학원) | 신호서열 및 변이된 신호서열로 디자인된 분비증강자에의한 원래 형태의 수용성 재조합 단백질 생산 방법 |
KR20100086717A (ko) * | 2009-01-23 | 2010-08-02 | 한국과학기술연구원 | 대장균에서 외래단백질을 분비 생산하는 방법 |
KR101992345B1 (ko) * | 2017-12-29 | 2019-09-27 | (주)메디톡스 | 프로모터 폴리뉴클레오티드, 신호 폴리펩티드 및 그의 용도 |
KR102176555B1 (ko) | 2019-08-06 | 2020-11-10 | 한국화학연구원 | 세포벽 재설계를 통한 스쿠알렌 생산이 증대된 균주 및 이를 이용한 스쿠알렌 생산방법 |
-
2021
- 2021-07-08 WO PCT/KR2021/008714 patent/WO2022065643A1/ko active Application Filing
- 2021-07-08 EP EP21872679.2A patent/EP4219533A1/en active Pending
- 2021-07-08 US US18/027,984 patent/US20240002888A1/en active Pending
- 2021-07-08 JP JP2023519309A patent/JP2023543041A/ja active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5726044A (en) * | 1994-09-14 | 1998-03-10 | Fuji Immunopharmaceuticals Corp. | Expression and export technology of proteins as immunofusins |
KR20070079025A (ko) * | 2006-01-31 | 2007-08-03 | 대한민국(관리부서:국립수산과학원) | 신호서열 및 변이된 신호서열로 디자인된 분비증강자에의한 원래 형태의 수용성 재조합 단백질 생산 방법 |
KR20100086717A (ko) * | 2009-01-23 | 2010-08-02 | 한국과학기술연구원 | 대장균에서 외래단백질을 분비 생산하는 방법 |
KR101992345B1 (ko) * | 2017-12-29 | 2019-09-27 | (주)메디톡스 | 프로모터 폴리뉴클레오티드, 신호 폴리펩티드 및 그의 용도 |
KR102176555B1 (ko) | 2019-08-06 | 2020-11-10 | 한국화학연구원 | 세포벽 재설계를 통한 스쿠알렌 생산이 증대된 균주 및 이를 이용한 스쿠알렌 생산방법 |
Non-Patent Citations (3)
Title |
---|
FREUDL ROLAND: "Signal peptides for recombinant protein secretion in bacterial expression systems", MICROBIAL CELL FACTORIES, vol. 17, no. 1, 1 December 2018 (2018-12-01), pages 52, XP055914048, DOI: 10.1186/s12934-018-0901-3 * |
GABRIELE R. M. KLEINER-GROTE, JOE M. RISSE, KARL FRIEHS: "Secretion of recombinant proteins from E. coli", ENGINEERING IN LIFE SCIENCES, WILEY, WEINHEIM, DE, vol. 18, no. 8, 1 August 2018 (2018-08-01), DE , pages 532 - 550, XP055677654, ISSN: 1618-0240, DOI: 10.1002/elsc.201700200 * |
LEE, JUN WON: "Improvement of Bacterial Endo-1,4-β-D-glucanase (CMCase) Secretion in Yeast by Mutagenesis of Gluco-amylase Signal Sequence", KOREAN JOURNAL OF APPLIED MICROBIOLOGY AND BIOTECHNOLOGY, vol. 28, no. 4, 1 January 2000 (2000-01-01), KR , pages 195 - 201, XP009535187, ISSN: 0257-2389 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2023227815A1 (es) * | 2022-05-24 | 2023-11-30 | Universitat Politècnica De València | Levadura y plásmido para la exposición de proteínas en superficie |
Also Published As
Publication number | Publication date |
---|---|
EP4219533A1 (en) | 2023-08-02 |
US20240002888A1 (en) | 2024-01-04 |
JP2023543041A (ja) | 2023-10-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Peng et al. | A squalene synthase protein degradation method for improved sesquiterpene production in Saccharomyces cerevisiae | |
Visser et al. | Metabolic engineering of the astaxanthin-biosynthetic pathway of Xanthophyllomyces dendrorhous | |
Kildegaard et al. | Engineering of Yarrowia lipolytica for production of astaxanthin | |
Tashiro et al. | Bacterial production of pinene by a laboratory-evolved pinene-synthase | |
Zhang et al. | Engineering yeast metabolism for production of terpenoids for use as perfume ingredients, pharmaceuticals and biofuels | |
Kawamukai | Biosynthesis of coenzyme Q in eukaryotes | |
Yao et al. | Genome mining of cyclodipeptide synthases unravels unusual tRNA-dependent diketopiperazine-terpene biosynthetic machinery | |
US8507235B2 (en) | Isoprene production using the DXP and MVA pathway | |
Yuan et al. | Efficient exploration of terpenoid biosynthetic gene clusters in filamentous fungi | |
Tokuhiro et al. | Overproduction of geranylgeraniol by metabolically engineered Saccharomyces cerevisiae | |
Takamatsu et al. | Characterization of a silent sesquiterpenoid biosynthetic pathway in Streptomyces avermitilis controlling epi‐isozizaene albaflavenone biosynthesis and isolation of a new oxidized epi‐isozizaene metabolite | |
Ducluzeau et al. | Gene network reconstruction identifies the authentic trans‐prenyl diphosphate synthase that makes the solanesyl moiety of ubiquinone‐9 in Arabidopsis | |
Szkopińska | Ubiquinone. Biosynthesis of quinone ring and its isoprenoid side chain. Intracellular localization. | |
Ye et al. | Revolution of vitamin E production by starting from microbial fermented farnesene to isophytol | |
WO2002053746A1 (en) | Process for producing prenyl alcohol | |
JP2018507698A (ja) | テルペンのデノボ微生物利用合成方法 | |
Ikeda et al. | Biosynthesis of mercapturic acid derivative of the labdane-type diterpene, cyslabdan that potentiates imipenem activity against methicillin-resistant Staphylococcus aureus: cyslabdan is generated by mycothiol-mediated xenobiotic detoxification | |
Wu et al. | Establishment of strigolactone-producing bacterium-yeast consortium | |
WO2022065643A1 (ko) | 분비 신호서열에 융합된 표적산물 결합 단백질을 코딩하는 폴리뉴클레오티드를 포함하는 재조합 미생물, 그를 포함하는 조성물 및 그를 이용하여 표적산물을 생산하는 방법 | |
WO2011053079A2 (ko) | 효모 변이주 및 이를 이용한 스쿠알렌의 생산 방법 | |
Du et al. | Engineering Saccharomyces cerevisiae for hyperproduction of β-amyrin by mitigating the inhibition effect of squalene on β-amyrin synthase | |
KR102170444B1 (ko) | 세포 소기관이 변이된 재조합 효모 및 이를 이용한 아이소프레노이드 생산 방법 | |
Wang et al. | Enhancing geranylgeraniol production by metabolic engineering and utilization of isoprenol as a substrate in Saccharomyces cerevisiae | |
Addlesee et al. | Rhodospirillum rubrum possesses a variant of the bchP gene, encoding geranylgeranyl-bacteriopheophytin reductase | |
EP3750989A1 (en) | Production of plant-based active substances (e.g. cannabinoids) by recombinant microorganisms |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 21872679 Country of ref document: EP Kind code of ref document: A1 |
|
ENP | Entry into the national phase |
Ref document number: 2023519309 Country of ref document: JP Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2021872679 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 2021872679 Country of ref document: EP Effective date: 20230428 |